Posted inBiotechnology
InnoCare, Keymed sell ex-China rights for bispecific to RTW-built biotech in $520M deal
Chinese biotechs InnoCare Pharma and KeyMed Biosciences have sold the international rights to a clinical-stage bispecific antibody to a new…






